Published on : May 13, 2016
ALBANY, New York, May 13, 2016: A new market research study, titled “Pharmaceutical Industry Business Outlook and Procurement Report H1 2016,” has recently been added by ResearchMoz.us to its comprehensive collection of research studies. The research report offers a detailed analysis of the pharmaceuticals industry for H1 2016 (April to September) period. The research study further talks about the impact of the major growth drivers and restraints on the demand for new products throughout the forecast period. The research report on global pharmaceuticals industry provides insights into new product development, expansion in the current market, and enhancement of operational efficiency. The report also covers the opportunities available for the major players engaged in the global pharmaceuticals industry.
According to pharmaceutical industry respondents, the developed markets, including the U.K., the U.S., and Japan are considered as the major regional segments for substantial growth in the next six months. Furthermore, around 52% of the pharmaceutical executives operating in Europe have assigned high preference for the outright purchasing of pharmaceutical equipment. On the other hand, in Asia Pacific, executives are expecting process and packaging equipment to provide substantial revenue generation opportunities across the pharmaceutical industry. The rapid growth of this region can be attributed to the provision of longer shelf life and avoidance of counterfeiting in the pharmaceutical packaging companies.
The research report highlights the major business priorities in the next six months in developing as well as developed nations. The study further throws light on the budget allocation, equipment and drug categories, any kind of change in capital expenditure, major mergers and acquisitions, purchase preference, and business concerns.
Click here to get more info with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=712126
According to the research study, Brazil, India, and China hold substantial potential to create opportunities for the growth of the global pharmaceutical industry in H1 2016. Increasing competition and market uncertainty are the major challenges affecting the growth of the global pharmaceuticals industry in the next six months. In addition, the restructuring of economic movement, a gradual slowdown in China, and the tightening of the monetary policy in the U.S. are further creating major concerns for the pharmaceutical industry.
Furthermore, the research study analyzes the major players operating in the global pharmaceuticals industry, wherein the detailed profiles of the dominant players have been mentioned. In addition, a SWOT analysis of these players and recent news and developments have also been discussed in a detailed manner. The results acquired from analytical tools, such as investment feasibility analysis and investment return analysis provide insights into market attractiveness, helping the major players in efficient decision making.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]